EDC Newsletter June 2008
Introducing Applied Clinical Trials' EDC News, a newsletter with news, articles, and information about EDC, IT, and eClinical.
Medidata Raves On EDC
Medidata's Rave EDC product has been moving in some interesting circles. In addition to becoming CDISC compliant, the products' accreditation program has been expanded so that CROs and other partners may achieve graduated levels of Rave service and support. Read about the CDISC initiatives here and about the Certification program here.
Almac Clinical Technologies
Almac Clinical Technologies provides phone and internet based interactive clinical technology solutions that improve the quality and efficiency of the clinical trial process. Our offerings include IVRS/ IXRS, iTrial EDC & ePRO.
www.almacgroup.com
eResearchTechnology
EDC Now! From eRTEDC is Evolving. eRT believes there is a better way.Visit us at DIA Booth# 800 for a demonstration!
invivodata
Clinical trial sponsors talked. We listened. Introducing the SitePRO® Tablet-the right size for site-based ePRO.
Management Forum's The CTD: An Introductory Overview
July 2, 2008
Location | London, UK
Pharmaceutical Information Management 2008
July 14–16, 2008
Location | Philadelphia, PA
CfPIE's FDA Inspections of Clinical Data Systems
July 17–18, 2008
Location | Costa Mesa, CA
Thomas Wells
- appointed OmniComm's vice president of technical operations.
Jim Walker
- of Octagon Research Solutions is a finalist in the American Business Awards.
Alan Gelenberg
- joins Healthcare Technology Systems as president, chief executive officer. (PDF)
Tim Pratt of MedNet Solutions (Minnetonka, MN) offers his comment on for-profit conferences in our industry. Click here to read more.
XClinical, a Germany-based EDC software vendor, participated in the CDISC Interchange in Japan earlier this month. Click here to read more.
Oncology-focused CRO ACORN (Memphis, TN) made its proprietary EDC system available to the clinical trials market. See the company press release here.
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
